
Frequent testing is crucial for detecting glaucoma progression in patients with ocular hypertension, according to a study analyzing 16,351 visual field tests from the Ocular Hypertension Treatment Study (OHTS) database. The research found that shorter testing intervals, specifically every 6 months for high-risk patients and every 12 months for low-risk patients, were most effective in detecting visual field progression. Computer simulations were used to estimate the time required to identify progression, emphasizing the importance of not missing the conversion to glaucoma. This suggests that tailoring testing intervals based on risk levels could optimize resource utilization in managing ocular hypertension.
Like
Save
Share